DWave Systems Shares Surge on Government Backing for Quantum Computing UK Inflation Eases as Retailers Flag Rising Fresh Food Costs Spain Blocks Access to Prediction Markets Kalshi and Polymarket Over Gambling Law Concerns Microsoft Appoints New Trusted Technology Head to Balance AI Speed with Responsible Development CNBC Investing Clubs Portfolio Rides Market Rally Top and Bottom Performers in SixWeek Record Run Wall Street Trading Muted as Uncertainty Clouds Mideast Peace Negotiations CBUS Q1 2026 Earnings Narrowing Losses Surpass Expectations as Operational Progress Continues LND Q1 2026 Earnings Negative EPS Reported Amid Challenging Agricultural Season ADPT Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Sentiment Patria Investments Q1 2026 Earnings EPS Falls Short of Estimates Amid Broader Market Pressure CleanSpark CLSK Q1 2026 Earnings Deep EPS Miss Fails to Dampen Investor Sentiment Kaltura Q1 2026 Earnings EPS Surprises to the Upside but Stock Slips Amid Revenue Uncertainty Nike NKE Edges Higher as Market Digests Subtle Gains Healthcare Triangle HCTI Edges Higher Consolidating Between Support and Resistance SLB Limited SLB Rallies 122 as Oil Services Stock Holds Above Key Support Primo Brands Corporation PRMB Gains 229 as Stock Approaches Key Resistance Morgan Stanley India Investment Fund IIF Rallies 135 as Emerging Market Sentiment Improves Lenovo Shares Surge Nearly 20 After Record Revenue and AI Revenue Doubles SOWG Q3 2025 Earnings Significant EPS Miss Amid Challenging Quarter CGTLs Sharp Decline Creative Global Technology Plunges 1230 Below Key Resistance Piper Sandler PIPR Holds Near Support Amid Modest Decline Fusemachines Inc FUSE Nudges Higher as Support Holds at 135 Cycurion Inc Warrant CYCUW Trades Flat at 002 as Support and Resistance Converge Wabash National Corporation WNC Edges Higher Amid Modest Volume Key Levels to Watch Inflection Point Acquisition Corp V Rights IPEXR Holds Steady at 060 as Traders Wait for Catalysts Aemetis AMTX Posts Modest Gain as Renewable Energy Stock Tests Resistance Amylyx Pharmaceuticals AMLX Declines 25 as Stock Tests Key Support